Intravitreal bevacizumab treatment of bilateral peripapillary choroidal neovascularization from optic nerve head drusen.

Knape, Robert M; Zavaleta, Eric M; Clark, Charles L; Khuddus, Nausheen; Peden, Marc C

Knape, Robert M; Zavaleta, Eric M; Clark, Charles L; Khuddus, Nausheen; Peden, Marc C.

Affiliation

Knape RM; Department of Ophthalmology, University of Florida College of Medicine, Gainesville, Florida 32610, USA. robknape@yahoo.com

J AAPOS ; 15(1): 87-90, 2011 Feb.

Article in En | MEDLINE | ID: mdl-21397813

Subject(s)

Angiogenesis Inhibitors/administration & dosage; Antibodies, Monoclonal/administration & dosage; Choroidal Neovascularization/drug therapy; Optic Disk Drusen/complications; Antibodies, Monoclonal, Humanized; Bevacizumab; Child, Preschool; Choroidal Neovascularization/diagnosis; Choroidal Neovascularization/etiology; Combined Modality Therapy; Fluorescein Angiography; Functional Laterality; Humans; Intravitreal Injections; Laser Coagulation; Male; Optic Disk; Optic Disk Drusen/diagnosis; Retreatment; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Visual Acuity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Optic Disk Drusen / Choroidal Neovascularization / Angiogenesis Inhibitors / Antibodies, Monoclonal Type of study: Diagnostic_studies / Etiology_studies Limits: Child, preschool / Humans / Male Language: En Journal: J AAPOS Journal subject: OFTALMOLOGIA / PEDIATRIA Year: 2011 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google